Does PEGINTERFERON BETA-1A Cause Mobility decreased? 195 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 195 reports of Mobility decreased have been filed in association with PEGINTERFERON BETA-1A (Plegridy Pen). This represents 1.6% of all adverse event reports for PEGINTERFERON BETA-1A.
195
Reports of Mobility decreased with PEGINTERFERON BETA-1A
1.6%
of all PEGINTERFERON BETA-1A reports
1
Deaths
76
Hospitalizations
How Dangerous Is Mobility decreased From PEGINTERFERON BETA-1A?
Of the 195 reports, 1 (0.5%) resulted in death, 76 (39.0%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGINTERFERON BETA-1A. However, 195 reports have been filed with the FAERS database.
What Other Side Effects Does PEGINTERFERON BETA-1A Cause?
Influenza like illness (1,431)
Injection site erythema (1,041)
Multiple sclerosis relapse (945)
Fatigue (673)
Headache (587)
Pain (580)
Injection site reaction (569)
Device malfunction (567)
Multiple sclerosis (536)
Pyrexia (503)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which PEGINTERFERON BETA-1A Alternatives Have Lower Mobility decreased Risk?
PEGINTERFERON BETA-1A vs PEGINTRON
PEGINTERFERON BETA-1A vs PEGLOTICASE
PEGINTERFERON BETA-1A vs PEGUNIGALSIDASE ALFA-IWXJ
PEGINTERFERON BETA-1A vs PEGVALIASE-PQPZ
PEGINTERFERON BETA-1A vs PEGVISOMANT